Şunu aradınız:: purposes of learning for the evaluation (Danca - Fince)

arrangements and schedule for the planned evaluation
arrangements and schedule for the planned evaluation

the european agency for the evaluation of medicinal products
euroopan lääkearviointivirasto

for the european community
for the european community

concept paper on the development of a cpmp note for guidance on requirements for the evaluation of new adjuvants in vaccines
note for guidance on the use of bovine serum in the manufacture of human biological medicinal products concept paper on the development of a cpmp note for guidance on requirements for the evaluation of new adjuvants in vaccines

concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia
concept paper on the development of a cpmp note for guidance on the evaluation of medicinal

the european agency for the evaluation of medicinal products emea/ mb/ 050/ 00
the european agency for the evaluation of medical products

guideline for competent authorities for the verification and evaluation of pharmacovigilance information for veterinary medicinal products
guideline for competent authorities for the verification and evaluation of pharmacovigilance information for veterinary medicinal products

concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction
concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction

concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment.
concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment.

concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal failure.
concept paper on the development of a cpmp note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal failure.

concept paper on the evaluation of drugs for the treatment of the irritable bowel syndrome
for the treatment of the irritable bowel syndrome note for guidance on clinical investigation

emea documentation service european agency for the evaluation of medicinal products 7 westferry circus canary wharf uk – london e14 4h
emea: n dokumentointipalvelu european agency for the evaluation of medicinal products 7 westferry circus canary wharf uk - london e14 4h

concept paper on the development of a cpmp points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population.
concept paper on the development of a cpmp points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population.

concept paper on the development of a cpmp points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections
concept paper on the development of a cpmp points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections

testing and evaluation of the efficacy of antiparasitic substances for the treatment and prevention of tick and flea infestation in cats and dogs
emea/ cvmp/ 005/ 00 and prevention of tick and flea infestation in cats and dogs

base currency the base currency for the purposes of this agreement shall be the us dollar or , at the ecb 's option , any other currency .
base currency the base currency for the purposes of this agreement shall be the us dollar or , at the ecb 's option , any other currency .

vedtaget af bestyrelsen den 18. december 2001 the european agency for the evaluation of medicinal products 7 westferry circus, canary wharf, london e14 4hb, united kingdom tel:
hallintoneuvosto hyväksyi tämän työohjelman 18. joulukuuta 2001 the european agency for the evaluation of medicinal products 7 westferry circus, canary wharf, london e14 4hb, united kingdom tel:

the careful examination at the evaluation committee , the discussions at the commission 's relevant group and the financial analysis constitute guarantees against fraud .
the careful examination at the evaluation committee , the discussions at the commission 's relevant group and the financial analysis constitute guarantees against fraud .

an age of learning — cedefops første rapport om erhvervsuddannelse på europæisk plan: kat.:hx­25­99­075­en­c. 146s.. 19 e.
an age of learning - cedefopin ensimmäinen raportti ammatillisesta koulutuksesta euroopassa. nro hx-25-99-075-en-c, 146 s.. 19 eur.

subscription service european agency for the evaluation of medicinal products 7 westferry circus canary wharf uk - london e14 4hb der kan abonneres på alle emea' s offentliggjorte dokumenter, enten i elektronisk udgave eller i papirformat.
subscription service european agency for the evaluation of medicinal products 7 westferry circus canary wharf uk - london e14 4h